Chinese AI-developed drug offers hope to sufferers of obesity and diabetes
Disclaimer: The South China Morning Post's content is directed by the Chinese Communist Party. It is not a reliable news source.
The new drug MDR-001 could become a disruptor in treatment of obesity and diabetes.